Xencor Gets License Payment From Boehringer Ingelheim
socalTECH
APRIL 4, 2012
Monrovia-based Xencor , the developer of antibody technology which is headed by Dr. Bassil Dahiyat, said today that it has received a second, milestone payment from Boehringer Ingelheim. Financial details and amount of the payment were not disclosed.
Let's personalize your content